RVTY

As of August 2, 2026, Revvity, Inc. has a market capitalization of $12.6 billion, making it a large-cap company in the Healthcare sector.

Of the 29 analyst ratings on Revvity, Inc., 52% are Buy or Strong Buy, 14 are Hold, and 0 are Sell. The overall consensus rating is Buy. Analyst ratings are opinions, not investment advice.

The average analyst price target for Revvity, Inc. is $111.57. Individual targets range from $95.00 to $125.00.

Revvity, Inc. is scheduled to report earnings on August 4, 2026. Analysts expect earnings of $1.21 per share.

Yes — Revvity, Inc. has paid $0.28 per share in dividends over the trailing twelve months.

RVTY has a beta of 1.09, meaning it has historically been more volatile than the broader market.

Revvity, Inc. operates in the Healthcare sector, the Medical - Diagnostics & Research industry, and its stock trades on NYSE.